IL-2 synergizes with proinflammatory type 3 inducers to amplify mixed type 2–type 3 inflammation in nasal polyps
Journal of Allergy and Clinical Immunology · 2026-05 · 157 (5) · 1071-1086
DOI: 10.1016/j.jaci.2026.02.010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Allergy and Clinical Immunology, 2026-05. Verfasst von Min Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, China; Beijing Laboratory of Aller…. Hauptthemen laut MEDLINE: Nasal Polyps, Rhinosinusitis, Interleukin-2, Inflammation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Chronic rhinosinusitis with nasal polyps involves mixed type 2-type 3 inflammation, associated with disease severity and treatment resistance, yet mechanisms remain unclear. OBJECTIVE: We sought to investigate the role of IL-2 and its interaction with type 3 inducers (TNF-α, IL-1β, and IL-23) in driving mixed type 2-type 3 inflammation. METHODS: IL-2 and receptor expression in nasal polyps was analyzed using tissue homogenates and public RNA-sequencing data. Dispersed nasal polyp cells were treated with IL-2/type 3 inducers, with cytokine production, proliferation, and gene expression analyzed via immunoassays, flow cytometry, and RNA sequencing. IL-2 receptor/Janus kinase (JAK) blockade studies were conducted. Furthermore, CD4+ and CD8+ T cells were magnetically isolated from nasal polyps to evaluate their response to cytokine stimulation. RESULTS: IL-2 levels were increased in chronic rhinosinusitis with nasal polyps, particularly in type 3-dominant and mixed type 2-type 3 subgroups, and correlated with type 3 cytokines. RNA sequencing supported upregulated IL-2 receptors and their coexpression with type 3 genes. IL-2 synergized with type 3 inducers to enhance both type 2 and type 3 cytokine production in dispersed nasal polyp cells. Direct functional evidence from isolated CD4+ and CD8+ T cells confirmed this synergy, with CD8+ T cells emerging as a novel source of IL-13. Flow cytometry further supported these findings, showing synergistic cytokine production across diverse cell populations, including T-cell subsets and natural killer cells. Memory T cells mediated T-cell receptor-independent cytokine production. Transcriptomic analysis identified activated type 3, type 2, and JAK-signal transducer and activator of transcription signaling pathways. IL-2 receptor blockade, particularly JAK inhibition, attenuated IL-2/type 3 inducer-mediated synergistic inflammation. CONCLUSIONS: A novel mechanism was identified whereby IL-2 synergizes with proinflammatory type 3 inducers to amplify mixed type 2-type 3 inflammation via innate-like T-cell activation, and targeted JAK inhibition was validated as a potential therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, China; Beijing Laboratory of Allergic Diseases, Beijing Municipal Education Commission, Beijing Key Labo…
- Department of Otolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
- Beijing Laboratory of Allergic Diseases, Beijing Municipal Education Commission, Beijing Key Laboratory of New Medicine and Diagnostic Technology Research for Nasal Disease, Beijing Institute of Otolaryngology, Beijing,…
- Department of Otorhinolaryngology-Head and Neck Surgery, University Hospital of Münster, Münster, Germany.
Zitieren
APA
Wang, M., Zhang, Q., Wang, Y., Sun, Y., Zhang, N., Liu, M., Meng, H., Li, Y., Wang, X., Zhang, L., & Bachert, C. (2026). IL-2 synergizes with proinflammatory type 3 inducers to amplify mixed type 2–type 3 inflammation in nasal polyps. Journal of Allergy and Clinical Immunology, 157(5), 1071-1086. https://doi.org/10.1016/j.jaci.2026.02.010
Vancouver
Wang M, Zhang Q, Wang Y, Sun Y, Zhang N, Liu M, et al. IL-2 synergizes with proinflammatory type 3 inducers to amplify mixed type 2–type 3 inflammation in nasal polyps. Journal of Allergy and Clinical Immunology. 2026;157(5):1071-1086. doi:10.1016/j.jaci.2026.02.010
BibTeX
@article{Wang2026,
author = {Wang, Min and Zhang, Qinqin and Wang, Yifei and Sun, Ying and Zhang, Nan and Liu, Mengdi and Meng, Haiyang and Li, Ying and Wang, Xiangdong and Zhang, Luo and Bachert, Claus},
title = {IL-2 synergizes with proinflammatory type 3 inducers to amplify mixed type 2–type 3 inflammation in nasal polyps},
journal = {Journal of Allergy and Clinical Immunology},
year = {2026},
volume = {157},
number = {5},
pages = {1071--1086},
doi = {10.1016/j.jaci.2026.02.010}
}
EUVIMED